Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Volunteer-led lifestyle program to help sarcopenia in older adults

Official title: The Effect of Volunteer-Engaged Lifestyle Optimisation Via ICOPE on Sarcopenia in Older Adults (VELO-S): A Randomised Controlled Trial

Run by The University of Hong Kong · NCT07345832 · Data updated 2026-11-12

This program tests a digital, volunteer-supported lifestyle plan to improve muscle health and reduce fall risk in older adults with sarcopenia or frailty.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment200 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedMarch 30, 2027
Study endsSeptember 30, 2027
Registry record updatedSeptember 8, 2026
Trial IDNCT07345832 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 60 years and older with documented sarcopenia or sarcopenia risk, who can use a smartphone or computer and are willing to participate.

Probably not a fit

Participants who do not respond to lifestyle changes or have medical conditions that limit physical activity may see little to no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The VELO-S project runs a 12-week, volunteer-engaged lifestyle optimisation pathway based on WHO ICOPE, delivered via a digital platform that personalises nutrition and exercise recommendations. It uses goal-oriented empowerment and workshops to sustain behavior change, while evaluating benefits for participants and the trained volunteers. The study also examines how social care workers view the intervention and how it is implemented in the community. Eligible participants are adults 60 and older with sarcopenia or risk markers, who can use digital devices and consent to participate. The study is hosted by The University of Hong Kong, with no listed collaborators beyond the lead sponsor.

Why it matters

Potential benefit: If successful, participants may experience improved muscle strength, better physical function, and a reduced risk of falls and hospitalisation.

How similar studies have gone: Prior similar approaches using digital health support and community volunteers have shown promise in supporting lifestyle changes for older adults, though results vary by setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. aged 60 or above
2. Pseudo-Sarcopenia as indicated by a score on SARC-CaIF ≥11, OR sarcopenia according relative BIA-based appendicular skeletal mass/ height (Men: \<7 kg/m2; women: \<5.7 kg/m2), OR handgrip strength on dominant hand (male \<28 kg, female \<18 kg) (Chen et al., 2025)
3. the ability to use a smartphone, electronic tablet, or computer
4. consent to participate

Exclusion Criteria:

1. having medical conditions contradictory to physical activity including unstable cardiovascular and orthopaedic conditions
2. engaging in other structured health promotion program involving physical activity and nutritional enhancement

Where it's running

  • The University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Doris Sau Fung YU, PhD — The University of Hong Kong
  • Study coordinator: Doris Sau Fung YU, PhD
  • Email: dyu1@hku.hk
  • Phone: 852-3917-6319

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.